EMBCEmbecta Corp.
What is the market doing?
No clear lean: nothing decisive, though heavily shorted (+10% of shares).
Choppy, but holding above its 200-day average. Price is +2% vs its 200-day average.
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How EMBC is trading
Embecta Corp. is −52% over the past year while the S&P 500 is +16%: 68 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +2.2%
vs 200-day average · close to trend
- RSI (14)
- 68
RSI (14) · neutral
- Below its 52-week high
- 53%
Below its 52-week high
Details›
- Last close2026-10-23
- $6.70
- 1 monthS&P 500 −0.94%
- +19%
- 1 yearS&P 500 +16%
- −52%
- vs 50-day average$5.61
- +19%
- 52-week high
- $14.20
- 52-week low
- $2.89
- Annualised volatility
- 72%
| Year | Return |
|---|---|
| 2026 (year to date) | −43% |
| 2025 | −40% |
| 2024 | +14% |
| 2023 | −23% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 4 | 1 of 4 | −7.2% |
| Feb | 4 | 1 of 4 | −5.0% |
| Mar | 4 | 0 of 4 | −9.6% |
| Apr | 5 | 1 of 5 | −6.9% |
| May | 5 | 2 of 5 | −14% |
| Jun | 5 | 2 of 5 | −6.0% |
| Jul | 5 | 4 of 5 | +11% |
| Aug | 5 | 4 of 5 | +17% |
| Sep | 5 | 1 of 5 | −6.8% |
| Oct | 5 | 3 of 5 | +4.1% |
| Nov | 4 | 3 of 4 | +18% |
| Dec | 4 | 1 of 4 | −6.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.
Medical Instruments & Supplies
Ranks #3 of 20 by RyuScore